A proof-of-concept analysis that demonstrates the utility of a neural network to predict the development of one or more comorbidities based on data routinely collected in primary care, published in Diabetes, a journal of the American Diabetes Association.
Details Metadvice is proud to announce that it started a collaboration with the Inselspital (Bern, Switzerland) supported by the Swiss innovation agency (Innosuisse) for a new project entitled:AI Companion for Diabetes Optimisation using Digital Data from Continuous Glucose Monitoring The project consists in transferring clinical knowledge for the management of people with diabetes from UDEM / Inselspital into an Artificial Intelligence that is capable of advising clinicians…
Details Announcement by Johnson & Johnson Innovation, April 29, 2022 Johnson & Johnson Innovation Names Awardees in the Immunology Innovations QuickFire Challenge: Precision Medicine in Immune-Mediated Disease On April 29 – the International Day of Immunology – Johnson & Johnson Innovation, together with Janssen Research & Development, announced that Metadvice and three other companies were awardees…
Details